Journal ArticleOPEN ACCESS

Understanding the company landscape in AI-driven biopharma R&D

  • Nagra N
  • Bleys J
  • Champagne D
  • et al.
Biopharma Dealmakers (2023)
DOI: 10.1038/d43747-023-00020-4
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The potential of companies developing artificial intelligence (AI)-based tools for drug discovery and development has driven investment and deals with major biopharma companies, but challenges for AI biotechs and biopharma companies are emerging as the field moves beyond the hype towards impact.

Cite

CITATION STYLE

APA

Nagra, N. S., Bleys, J., Champagne, D., Devereson, A., & Macak, M. (2023). Understanding the company landscape in AI-driven biopharma R&D. Biopharma Dealmakers. https://doi.org/10.1038/d43747-023-00020-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free